BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21917737)

  • 1. Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.
    Gomez-Roca CA; Lacroix L; Massard C; De Baere T; Deschamps F; Pramod R; Bahleda R; Deutsch E; Bourgier C; Angevin E; Lazar V; Ribrag V; Koscielny S; Chami L; Lassau N; Dromain C; Robert C; Routier E; Armand JP; Soria JC
    Ann Oncol; 2012 May; 23(5):1301-1306. PubMed ID: 21917737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.
    El-Osta H; Hong D; Wheler J; Fu S; Naing A; Falchook G; Hicks M; Wen S; Tsimberidou AM; Kurzrock R
    Oncologist; 2011; 16(9):1292-8. PubMed ID: 21859821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.
    Dowlati A; Haaga J; Remick SC; Spiro TP; Gerson SL; Liu L; Berger SJ; Berger NA; Willson JK
    Clin Cancer Res; 2001 Oct; 7(10):2971-6. PubMed ID: 11595684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy.
    Hong DS; George GC; Iwuanyanwu EC; Tavana B; Falchook GS; Piha-Paul SA; Wheler JJ; Mistry RH; Lei X; Kurzrock R
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):963-70. PubMed ID: 23455881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
    Lee JM; Hays JL; Noonan AM; Squires J; Minasian L; Annunziata C; Wood BJ; Yu M; Calvo KR; Houston N; Azad N; Kohn EC
    Cancer; 2013 Apr; 119(7):1357-64. PubMed ID: 23280317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' perceptions of research biopsies in phase I oncology trials.
    Lemech C; Dua D; Newmark J; Saggese M; Simmons E; Spiliopoulou P; Arkenau HT
    Oncology; 2015; 88(2):95-102. PubMed ID: 25322682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit Experience.
    Biondo A; Pal A; Riisnaes R; Shinde R; Tiu C; Lockie F; Baker C; Bertan C; Crespo M; Ferreira A; Pereira R; Figueiredo I; Miranda S; Gurel B; Carreira S; Banerji U; de Bono J; Lopez J; Tunariu N; Minchom A
    Cancer Treat Res Commun; 2021; 27():100309. PubMed ID: 33549985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01).
    Tacher V; Le Deley MC; Hollebecque A; Deschamps F; Vielh P; Hakime A; Ileana E; Abedi-Ardekani B; Charpy C; Massard C; Rosellini S; Gajda D; Celebic A; Ferté C; Ngo-Camus M; Gouissem S; Koubi-Pick V; Andre F; Vassal G; Deandreis D; Lacroix L; Soria JC; De Baère T
    Eur J Cancer; 2016 May; 59():79-89. PubMed ID: 27017289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Biopsies: An Integrative Review of the Experiences of Patients With Cancer.
    Abraham E; Post K; Spring L; Malvarosa G; Tripp E; Peppercorn JM; Bardia A; Habin K
    Clin J Oncol Nurs; 2018 Jun; 22(3):E71-E77. PubMed ID: 29781452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials.
    Sweis RF; Drazer MW; Ratain MJ
    J Clin Oncol; 2016 Feb; 34(4):369-74. PubMed ID: 26668350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
    Goranova T; Ennis D; Piskorz AM; Macintyre G; Lewsley LA; Stobo J; Wilson C; Kay D; Glasspool RM; Lockley M; Brockbank E; Montes A; Walther A; Sundar S; Edmondson R; Hall GD; Clamp A; Gourley C; Hall M; Fotopoulou C; Gabra H; Freeman S; Moore L; Jimenez-Linan M; Paul J; Brenton JD; McNeish IA
    Br J Cancer; 2017 May; 116(10):1294-1301. PubMed ID: 28359078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.
    Lee K; Lee SJ; Yoon S; Ryoo BY; Kim SW; Choi SH; Lee SM; Chae EJ; Park Y; Jang SJ; Park SY; Yoon YK; Park SH; Kim TW
    PLoS One; 2019; 14(8):e0221065. PubMed ID: 31404103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of Patients With Gastrointestinal Cancers Toward Research Biopsies.
    Moorcraft SY; Begum R; Cunningham D; Peckitt C; Baratelli C; Gillbanks A; Rogers P; Nwokorie V; Chau I; Watkins D; Starling N
    Clin Colorectal Cancer; 2017 Sep; 16(3):e181-e189. PubMed ID: 27839727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle biopsies in clinical trials for Duchenne muscular dystrophy - Patients' and caregivers' perspective.
    Verhaart IEC; Johnson A; Thakrar S; Vroom E; De Angelis F; Muntoni F; Aartsma-Rus AM; Niks EH
    Neuromuscul Disord; 2019 Aug; 29(8):576-584. PubMed ID: 31378431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?
    Prud'homme C; Deschamps F; Allorant A; Massard C; Hollebecque A; Yevich S; Ngo-Camus M; Gravel G; Nicotra C; Michiels S; Scoazec JY; Lacroix L; Solary E; Soria JC; De Baere T; Tselikas L
    Eur J Cancer; 2018 Nov; 103():108-119. PubMed ID: 30223224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.
    Agulnik M; Oza AM; Pond GR; Siu LL
    J Clin Oncol; 2006 Oct; 24(30):4801-7. PubMed ID: 17050865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.